Hualan Biological Engineering
002007.SZ
$2.70
Share price
-0.86%
Change (1 day)
-16.59%
Change (1 year)
Categories
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.
Revenue for Hualan Biological Engineering (002007.SZ)
Revenue in 2023 (TTM): $0.75 B
According to Hualan Biological Engineering's latest financial reports the company's current revenue (TTM
) is $0.73 B.
In 2022 the company made a revenue of $0.66 B a decrease over the years 2021 revenue that were of $0.68 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Hualan Biological Engineering from 2004 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.75 B | 13.23% |
| 2022 | $0.66 B | -3.26% |
| 2021 | $0.68 B | -7.44% |
| 2020 | $0.74 B | 39.45% |
| 2019 | $0.53 B | 11.04% |
| 2018 | $0.47 B | 35.33% |
| 2017 | $0.35 B | 22.34% |
| 2016 | $0.28 B | 24.16% |
| 2015 | $0.23 B | 15.84% |
| 2014 | $0.20 B | 10.32% |
| 2013 | $0.18 B | 17.88% |
| 2012 | $0.15 B | 3.39% |
| 2011 | $0.14 B | -20.27% |
| 2010 | $0.18 B | 5.01% |
| 2009 | $0.17 B | 158.02% |
| 2008 | $69.28 M | 48.46% |
| 2007 | $46.67 M | 4.62% |
| 2006 | $44.6 M | 0.81% |
| 2005 | $44.25 M | 14.03% |
| 2004 | $38.8 M |